Sensitive and quantitative cytokine detection in bats

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 1R03AI156632-01

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2021
    2023
  • Known Financial Commitments (USD)

    $149,088
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    Nicole Ann Kruh-Garcia
  • Research Location

    United States of America
  • Lead Research Institution

    Colorado State University
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Project Summary / AbstractBats have gained attention in recent years as reservoir or suspected reservoir hosts of many high-impact humanpathogenic viruses that cause outbreaks and epidemics with high case-fatality rates. Genome and transcriptomeanalyses suggest the immune systems of bats are substantially similar to those of other mammals. Howeverdifferences in the overall immunological response to viral exposure exist-allowing for bats to remain resistantviral reservoirs, while other mammals are highly susceptible. Due to the dearth of available antibody reagents tomonitor the abundance of cytokines during infection, little research into their immune systems and responseshas been conducted. Gene expression analyses can provide some indication of cytokine levels, howeverquantitation of immune proteins at multiple time-points during infection, in conjunction with end-point RNAanalysis, would be ideal. The lack of available bat antibody reagents poses a unique challenge in fullycharacterizing the immune response to infectious agents in this animal model. To overcome this hurdle, we aimto generate highly sensitive and specific targeted mass spectrometry assays to detect and quantify immuneproteins in complex matrices, such as biological fluids and tissue homogenates, from naïve bats and thoseinfected with virus.